Steven joins Binney Street Capital as a Principal after serving in both scientific and business development roles at Dana-Farber.
Steven is a scientist with a strong publication record and experience commercializing academic technologies into new companies. Steven co-founded SanaRx BioTherapeutics, Raqia Therapeutics, and NextRNA. Steven also served as the Alliance Manager for Dana-Farber’s collaboration with MPM Capital.
Steven received his PhD in Immunology from the Mayo Clinic and completed his postdoctoral work at Dana-Farber under Dr. Carl Novina. He received a BS in mathematics, Phi Beta Kappa & Summa Cum Laude, from Union College.
Steven is attending / has attended:
Venture Summit Virtual Connect | Global 21